A
$ Value
$15K
Shares
5,000
Price
$3
Filed
Jul 1
Insider
Name
Rahmer Peter
Title
See remarks
CIK
0001959229
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
395,081
Footnotes
The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction. | In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2025. | Includes 204,715 shares underlying RSUs.
Filing Info
Rahmer Peter's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-29 | RLAY | ▼ | $160K |
| 2025-10-28 | RLAY | ▼ | $139K |
| 2025-07-29 | RLAY | ▼ | $58K |
| 2025-07-28 | RLAY | ▼ | $5K |
| 2025-06-30 | RLAY | A | $15K |
| 2025-04-30 | RLAY | ▼ | $32K |
| 2025-04-28 | RLAY | ▼ | $4K |
Other Insiders at RLAY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Catinazzo Thomas
Chief Financial Officer
|
— | $257K | 2026-04-09 |